Ele foi desenvolvido originalmente para o tratamento do diabetes tipo 2, ajudando a regular a glicemia de forma mais eficiente
Botta D, Franklin CC, White CC, Krejsa CM, Dabrowski MJ, Pierce RH et al
J.DiMarchiR.TschopM
TGF-1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation
The anti-inflammatory properties of GLP-1 receptor agonists may also be relevant, as chronic microglial activation and inflammatory cytokine production are prominent features of Alzheimer's pathology
It works the same way mechanistically, activating the GLP-1 receptor to reduce appetite, slow gastric emptying and improve insulin sensitivity, but the small molecule structure means it can be taken orally with fewer absorption constraints. In trials, orforglipron lowered blood sugar and produced meaningful weight loss in people with obesity and in those with type 2 diabetes, says LaValle